Standardizing the Definition and Analysis Methodology for Complete Coronary Artery Revascularization

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

Ovidiu Dressler¹  Ziad A. Ali¹  Gregg W. Stone¹  Jennifer Horst¹  Maria A. Alfonso¹  Jeffrey W. Moses²  David J. Maron³  Leslee J. Shaw⁴  Judith S. Hochman⁵  Harmony Reynolds⁵  Sripal Bangalore⁵  Prakriti Gaba⁶  Mahesh V. Madhavan⁶ 

[1] Clinical Trials Center Cardiovascular Research Foundation New York NY;DeMatteis Cardiovascular Institute St. Francis Hospital Roslyn NY;Department of Medicine Stanford University Stanford CA;Department of Radiology NewYork‐Presbyterian Hospital and Weill Cornell Medicine New York NY;New York University Grossman School of Medicine New York NY;New York‐Presbyterian Hospital/Columbia University Irving Medical Center New York NY;

关键词: coronary artery bypass;    percutaneous coronary intervention;    revascularization;   

DOI  :  10.1161/JAHA.120.020110

来源: DOAJ

【 摘 要 】

Abstract Guideline‐based medical therapy is the foundation of treatment for individuals with coronary artery disease. However, revascularization with either percutaneous coronary intervention or coronary artery bypass grafting may be beneficial in patients with acute coronary syndromes, refractory symptoms, or in other specific scenarios (eg, left main disease and heart failure). While the goal of percutaneous coronary intervention and coronary artery bypass grafting is to achieve complete revascularization, anatomical and ischemic definitions of complete revascularization and their methodology for assessment remain highly variable. Such lack of consensus invariably contributes to the absence of standardized approaches for invasive treatment of coronary artery disease. Herein, we propose a novel, comprehensive, yet pragmatic algorithm with both anatomical and ischemic parameters that aims to provide a systematic method to assess complete revascularization after percutaneous coronary intervention or coronary artery bypass grafting in both clinical practice and clinical trials.

【 授权许可】

Unknown